News & Resources
Caesar Rivise Law Firm Opens Lehigh Valley Office
Posted on Oct 7, 2014 in News
Caesar Rivise, PC is pleased to announce that it has opened an office in Allentown, Pennsylvania. The office will service the needs of existing clients in the Lehigh Valley and will provide a full range of services in intellectual property law and litigation. The office is located within two blocks of the Federal Courthouse and the Court of Common Pleas of Lehigh County.
Read MoreExpediting Software-Related Patent Applications in the U.S. Patent and Trademark Office Using Glossary Pilot Program
Posted on Sep 24, 2014 in Blog
The U.S. Patent and Trademark Office (PTO) recently initiated a pilot program that allows software-related patent applications that are accepted in the program to receive expedited processing and examination. Accepted applications are placed on the examiner’s special docket prior to the first Office Action, and receive “special status” up to issuance of a first Office Action.
Read MoreDiversity Council Multicultural Leadership Award
Posted on Sep 22, 2014 in News
Earlier this month, the Philadelphia Diversity Council awarded its Multicultural Leadership Award to firm partner Michael Cornelison. The award recognizes individuals who demonstrate leadership excellence in their field of work and commitment to community well-being. Congratulations Mike!
Read MoreCAFC in STC.UNM v. Intel Corp. Affirms Dismissal of Patent Infringement Suit in Which Co-Owner Refused to Join
Posted on Sep 19, 2014 in Blog
In STC.UNM v. Intel Corporation, case number 13-1241, decided September 17, 2014, the Court of Appeals for the Federal Circuit (“CAFC”), in a 6-4 decision, refused to conduct an en banc review of its prior panel decision dismissing a patent infringement suit brought by the licensing arm of the University of New Mexico against Intel Corporation (“Intel”),
Read MoreAre You Able to Extend Your Patent’s Term of Enforcement?
Posted on Sep 3, 2014 in Articles
The U.S. Constitution provides to inventors the exclusive right to their discoveries “for limited times.” Patents are thus granted with limited terms of enforcement. Is there a way to extend the term of a patent? Is there a way to increase the time period during which a patent can be monetized? In some situations, the answer to both questions is a resounding “yes.”
Read MoreBest Lawyers in America
Posted on Sep 2, 2014 in News
We are pleased to announce that nine lawyers from Caesar Rivise were recently selected by their peers for inclusion in The Best Lawyers in America© 2015 in the fields of Patent Law, Trademark Law, Copyright Law, Trade Secrets Law, Litigation–Patent, and Litigation–Intellectual Property.
Read MoreCRBCP Attorneys to Attend the Society for Imaging Science and Technology NIP30 Conference
Posted on Sep 2, 2014 in Events
Caesar Rivise attorneys Scott Slomowitz, Gary Greene and Nick Tinari (not shown) will be hosting a booth at the Society for Imaging Science and Technology NIP30 Conference at the Sheraton Philadelphia on September 9 and 10, 2014. Please look for our booth if you are attending.
Read MoreThe Washington Redskins Come Back Fighting
Posted on Aug 27, 2014 in Blog
On June 25, 2014, we blogged that the U.S. Patent and Trademark Office cancelled six trademark registrations owned by the Washington Redskins, ruling that the term “Redskins” was disparaging. On August 14, 2014, the owner of the Washington Redskins came back fighting with a new federal lawsuit (Pro-Football, Inc. v. Amanda Blackhorse et al., Case No. 1:14-cv-01043, E.D. Va.) asking the U.S. District Court for the Eastern District of Virginia to overturn the U.S. Patent and Trademark Office’s cancellations, asserting that the Redskin marks do not disparage Native Americans.
Read MoreU.S. House of Representatives Panel to Investigate Abuse of U.S. Patent And Trademark Office Telework Program
Posted on Aug 26, 2014 in Blog
The U.S. Patent and Trademark Office’s “telework” program came under fire when news emerged, first reported in an August 10, 2014 Washington Post article, that oversight of patent examiners who work from home at various locations around the country was “completely ineffective.”
Read MoreResounding Victory in New Jersey Follows Successful Transfer of Pharmaceutical Patent Infringement Litigation from Ohio
Posted on Aug 8, 2014 in News
A New Jersey federal judge on August 6, 2014 rejected Roxane Laboratories, Inc.’s bid for a preliminary injunction in its patent suit over Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc.’s generic calcium acetate capsule product, which is used in the treatment of hyperphosphatemia in patients with chronic kidney disease.
Read More